The 'unknown' safety concern for aripiprazole once monthly.

Fleischhacker et al report that treatment-emergent adverse effects are comparable for aripiprazole 400 mg once monthly and a suboptimal dose (50 mg) of aripiprazole once monthly.[1][1] Also, they state that the ‘clinical relevance’ of statistically significant difference in Barnes Akathisia